Last month, the drug, BMS-986094, was implicated in the death of Brian Starkey and the hospitalization of at least eight other people with heart and kidney damage, creating a medical catastrophe of a magnitude rarely seen in drug research. International pharmaceutical giant Bristol-Myers Squibb spent $2.5 billion to acquire the company that created the drug
Related
Bristol-Myers Squibb Discontinues Development of BMS-986094
Leave a Reply
You must be logged in to post a comment.